Marksans Pharma (NSE:MARKSANS) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MARKSANS Marksans Pharma Ltd NSE:MARKSANS
90 GF Score
Price ₹269.30
GF Value ₹228.66
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Marksans Pharma Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:MARKSANS vs LLY, JNJ, ABBV: Short Percentage of Float Comparison

For the Drug Manufacturers - General subindustry, Marksans Pharma's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Marksans Pharma Short Percentage of Float vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Marksans Pharma's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Marksans Pharma's Short Percentage of Float falls into.


NSE:MARKSANS
90GF Score
Marksans Pharma Ltd NSE:MARKSANS
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Marksans Pharma (NSE:MARKSANS) Overvalued in 2026?

Based on GuruFocus' analysis, Marksans Pharma stock appears to be overvalued. The current stock price of ₹269.30 is trading 17.8% above its estimated GF Value™ of ₹228.66. GuruFocus considers Marksans Pharma to be Modestly Overvalued.

Key valuation signals for NSE:MARKSANS:

  • Short Percentage of Float:
  • GF Value™: ₹228.66 vs. price of ₹269.30 (17.8% above fair value)
  • GF Score™: 90/100 with 6 warning signs

No single metric tells the full story. See the NSE:MARKSANS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Marksans Pharma Business Description

Other Exchanges 524404:India
Address Veera Desai Extension Road, 11th Floor, Grandeur, Opposite Gundecha Symphony, Oshiwara, Andheri (West), Mumbai, MH, IND, 400053
Marksans Pharma Ltd is a pharmaceutical company. The company is engaged in the research, manufacturing, and marketing of pharmaceutical formulations. It manufactures analgesics, gastroenterology, anti-diabetic, cardiovascular, pain management, gynecology, gastrointestinal, and oncologic drugs as well as antibiotics and antiallergic medications. Geographically, the majority of its revenue is generated from the United States and North America, followed by Europe and the UK, Australia and New Zealand, and the Rest of the World.
90GF Score

Get the complete analysis for NSE:MARKSANS

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹269.30
Price
₹228.66
GF Value